Injectable medicines used for weight loss

We are currently awaiting the publication of the local prescribing pathway in Sussex for GLP-1 (injectable medicines used for weight loss) , such as Mounjaro (Tirzepatide), which will outline how these treatments can be accessed through General Practice. Once this guidance is available, we will contact patients who are eligible for the first phase of the rollout directly.

In the meantime, GLP-1 (injectable medicines used for weight loss) may be accessed through existing referral pathways for patients who meet the necessary clinical criteria. These form part of a broader range of weight management support options available across Sussex, including non-pharmaceutical interventions.

For the most up-to-date information on weight management services and support available in Sussex, please visit here.

Published: Jun 25, 2025